People with MS experience significant changes in cognition more than a year before significant physical decline is evident, a ...

At the Type B end-of-Phase 2 MS meeting with the U.S. Food and Drug Administration, FDA aligned with Clene acknowledging the limitations of the Expanded Disability Status Scale and expressed openness ...

By Dennis Thompson HealthDay ReporterTHURSDAY, Sept. 25, 2025 (HealthDay News) — A growing number of Americans appear to be ...

There’s a good chance that you haven’t heard about a rare condition called chromhidrosis. In a nutshell, the person afflicted with the disease produces colored sweat, from yellow to green, even red ...

Epilepsy Action Council of Management forms the policy of the charity and is responsible for overseeing sound management of ...

A landmark placebo-controlled trial shows shunting improves walking and reduces falls in idiopathic normal-pressure ...

A growing number of U.S. adults—particularly those under 40—are reporting serious challenges with memory, concentration and decision-making, according to a new study published in the September 24, ...

A recent study reveals a concerning rise in cognitive difficulties among U.S. adults, particularly in memory, concentration, ...

In six massive laboratory freezers at the University of Utah, nearly 40,000 blood samples wait in frozen stasis.

A growing number of U.S. adults-particularly those under 40-are reporting serious challenges with memory, concentration and decision-making, according to a new study published in the September 24, ...

The Lancet review synthesises evidence on anti beta amyloid monoclonal antibodies and the wider Alzheimer’s care pathway, ...